Search the Newsreel

AMREP (NYSE:AXR) CFO Sells $93,960.00 in Stock

AMREP's CFO, Adrienne Uleau, sold 4,000 shares of company stock for a total of $93,960.00, reducing her direct holdings by 37.83%. This transaction follows the company's recent quarterly earnings which missed analyst expectations for both EPS and revenue. The stock traded below its 50-day …

Bragar Eagel & Squire, P.C. is Investigating Replimune

Bragar Eagel & Squire, P.C., a stockholder rights law firm, is investigating potential claims against Replimune Group Inc. following a significant stock drop. The investigation comes after the FDA deemed Replimune's single-arm mid-stage study for its drug RP1 for skin cancer as "not interpretable," …

Republic Services Number of Employees 2026 | Employee Count & Headcount Data

Republic Services, Inc. (RSG) had approximately 42,084 total employees worldwide as of March 2026, marking a 0.6% decline from 2025. The company is actively hiring with 2,886 job postings in 2026, though new postings per month have cooled. The majority of its workforce is …

IRSA (NYSE: IRS) inks $4M Ramblas del Plata barter deal

IRSA Inversiones y Representaciones S.A. (NYSE: IRS) has signed a $4 million barter agreement for a new 2,360 sqm lot within the extended first stage of its Ramblas del Plata real estate project. The lot has an estimated total saleable area of 4,500 sqm. …

Repligen (RGEN) Stock Faces A Margin Puzzle After Revenue Growth

Repligen (RGEN) recently reported Q2 2026 earnings with revenue growth and expanded adjusted gross and operating margins, despite a slip in net income. The article discusses the bull and bear cases for the stock, focusing on the company's shift towards recurring revenue and its …

Mesa Air Group Q2 Earnings Call Highlights

Key Points Interested in Mesa Air Group, Inc.? Here are five stocks we like better. Second-quarter performance improved: Republic Airways increased block-hour production 7% sequentially and revenue 8% to approximately $571 million. Adjusted net income was $41 million, or $0.89 per diluted share, while …

Republic Services Inc. stock outperforms competitors despite losses on the day

Shares of Republic Services Inc. (RSG) fell by 3.46% to $211.33 on Thursday, despite a strong day for the broader stock market with the S&P 500 Index and Dow Jones Industrial Average both rising. The company's stock closed 12.28% below its 52-week high reached …

3 Promising Penny Stocks With Market Caps Up To $200M

This article identifies three promising penny stocks with market caps up to $200 million: KORU Medical Systems (KRMD), Planet Image International (YIBO), and Zevia PBC (ZVIA). Despite a recent drop in the U.S. market, these companies exhibit potential for growth, robust financial health, and …

Replimune’s RP-1 for melanoma wins over FDA adcom

Replimune Group Inc.'s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma, refractory to PD-1 therapy, received a positive vote from the U.S. FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee. The committee voted 10-3 that the efficacy results from the Ignyte phase II study …

Replimune: 'Sell' Continued Doubt On Single-Arm IGNYTE Trial For RP1 FDA Review (REPL)

Replimune Group, Inc. has been downgraded to 'Sell' due to ongoing FDA concerns regarding its RP1 + OPDIVO combination for advanced melanoma. The FDA's briefing documents highlight issues with the reliance on the single-arm IGNYTE trial, lack of a control arm, and a questionable …

KORU Medical Systems, Inc. (NASDAQ:KRMD) Given Consensus Rating of "Moderate Buy" by Brokerages

KORU Medical Systems (NASDAQ:KRMD) has received a "Moderate Buy" consensus rating from brokerages, with an average 12-month price target of $7.25. Insiders have recently purchased shares worth approximately $109,430, and the stock traded up 0.9% to $4.11. The company develops and manufactures medical devices …

Republic Services (RSG) Earnings Expected to Grow: Should You Buy?

Wall Street expects a year-over-year increase in earnings on higher revenues when Republic Services (RSG) reports results for the quarter ended June 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term …

Wall Street Analysts Believe Repligen (RGEN) Could Rally 25.72%: Here's is How to Trade

Repligen (RGEN) closed the last trading session at $141.23, gaining 1.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of …

Republic Services invests $973M in sustainability, advancing 2030 goals with new RNG projects and electric fleet expansion

Republic Services invested $973 million in sustainability initiatives in 2025, including nine renewable natural gas projects and expanding its electric truck fleet to over 180 vehicles. These investments support the company's 2030 goals related to safety, talent, climate leadership, and community impact. The company …

IRSA director Fernando Adrian Elsztain sells 5,524 common shares for USD 9,336.56

Fernando Adrian Elsztain, a director at IRSA, sold 5,524 common shares for USD 9,336.56 on April 9, 2026, at a price of USD 1.69 per share. Following this transaction, his direct holding in common shares of IRSA has fallen to zero. The Form 4 …

RAM Essential Services Property Fund Revenue Breakdown – ASX:REP

Republic Services Expands Electric Fleet to More Than 180 Trucks

Republic Services (NYSE:RSG) released its 2025 Sustainability Report, detailing nearly $1 billion in investments towards its 2030 Safety, Talent, Climate Leadership, and Communities goals. Key investments include nine new renewable natural gas projects and expanding its electric collection fleet to over 180 trucks. The …

Replimune Faces FDA Panel on RP1 Melanoma Therapy

Replimune will present data for its RP1 plus nivolumab therapy for advanced melanoma to an FDA advisory panel. The company is seeking accelerated approval for RP1, citing positive outcomes from the IGNYTE trial and previous FDA feedback, arguing its efficacy and safety profile justify …

Replimune Seeks FDA Advisory Committee Backing for RP1 + nivolumab; IGNYTE ORR 33.6% & DOR 24.8 mos

Replimune

Repligen (NASDAQ:RGEN) Combines Strong Growth with a Promising Technical Breakout Setup

Repligen (NASDAQ:RGEN) is highlighted as a compelling stock due to its strong fundamental growth, including significant revenue and EPS increases, combined with a promising technical breakout setup. The company shows an impressive growth rating with accelerating EPS expectations, despite an elevated valuation. Technically, RGEN …

IRSA Inversiones y Representaciones SA Sponsored ADR Revenue Breakdown – DUS:IRY

This article provides a revenue breakdown for IRSA Inversiones y Representaciones SA Sponsored ADR (DUS:IRY), highlighting that Argentina was the largest contributor to its revenue. Last year, Argentina accounted for €306.65 million, a decrease from €402.03 million the previous year. The data is presented …

Flash de resultados: Ferrari supera las previsiones en el segundo trimestre con un beneficio por acción de 2,62 EUR frente a los 2,47 EUR estimados

Republic Airways Holdings: Q2 Earnings Snapshot

Republic Airways Holdings Inc. Announces Q2 2026 Financial Results And Increases Full Year Guidance

Republic Airways Holdings Inc. reported strong financial results for the second quarter of 2026, including revenues of $571.1 million and a net income of $31.2 million, driven by increased block hour production and the integration of Mesa Airlines. The company also raised its full-year …

Is It Too Late To Consider Buying AMREP Corporation (NYSE:AXR)?

AMREP Corporation (NYSE:AXR) saw significant share price movement recently. According to Simply Wall St's price multiple model, the stock is currently a bargain, trading below the industry average P/E ratio. However, the company is expected to deliver negative earnings growth of -1.4%, introducing some …

Republic Services (RSG) Expected to Post Quarterly Earnings on Thursday

Republic Services (RSG) is projected to release its Q2 2026 earnings on Thursday, August 6th, with analysts anticipating $1.82 EPS and $4.364 billion in revenue. The company's previous quarter surpassed expectations, and it also pays a quarterly dividend of $0.625. Wall Street currently holds …

Republic Bancorp (NASDAQ:RBCAA) Breaks Into New Territory

Replimune Group (REPL) Projected to Announce Quarterly Earnings on Thursday

Republic Airways expects Mesa merger integration to take 18-24 more months

Republic Airways Holdings Inc (RJET) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth ... By GuruFocus

Ferrari eleva su guía para 2026 pese a resultados del segundo trimestre inferiores a lo esperado

Beforepay (ASX:B4P) Shares Jump After Record Margin and Profit Growth Update

PT Telkom Indonesia (Persero) Tbk Class B Revenue Breakdown – SWB:TCID

PT Telkom Indonesia (Persero) Tbk Class B (SWB:TCID) generated €7.50 billion in revenue last year. The "Business to Customer" segment was the top-performing segment, contributing €5.41 billion, while Indonesia accounted for the largest geographical contribution with €7.04 billion in revenue.

Earnings Preview: Sarepta Therapeutics (SRPT) Q2 Earnings Expected to Decline

Sarepta Therapeutics (SRPT) is expected to report a significant year-over-year decline in Q2 earnings and revenues. While analysts have recently become more bullish on the company based on a higher Most Accurate Estimate, Sarepta's Zacks Rank of #4 makes a definitive prediction of an …

Replimune Group Number of Employees 2026 | Employee Count & Headcount Data

Replimune Group, a Pharmaceuticals company founded in 2015 and headquartered in Woburn, Massachusetts, had approximately 469 employees worldwide as of March 2026, representing a 35.9% growth from 2023 but a 1.2% decline year-over-year. The company's workforce is concentrated in the United States, followed by …

Repligen Corp Q2 2026: Revenue $204.1M, EPS $0.09— 10-Q Summary

Repligen Corp (RGEN) reported its second-quarter 2026 results, with revenue increasing by 11.9% year-over-year to $204.1 million. Despite the revenue growth, net income declined to $5 million, and diluted earnings per share fell to $0.09 from $0.26 in the prior-year quarter. The company also …